Jersey Shore NJ
Moleculin Biotech, Inc. Reports Financial Results for the Year Ended December 31, 2019
HOUSTON, March 19, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug c…
